Insuvia is Among FT1000 Fastest Growing Companies for the 4th Time

Insuvia has once again been named on the Financial Times 1000 Fastest Growing Companies in Europe list. This marks our fourth consecutive year on the ranking, with Insuvia placed at number 503.

Being listed four years in a row matters. It shows sustained growth, not a one off spike. It reflects a business built to last, with consistent demand for high quality pharmacovigilance and regulatory affairs services across Europe and beyond.

The FT1000 list is compiled annually by the Financial Times and Statista, ranking companies based on verified revenue growth over a multi year period. Remaining on this list year after year confirms that Insuvia continues to scale responsibly while delivering reliable value to pharmaceutical and biotech partners.

Built by People, Strengthened by Trust

This recognition belongs first and foremost to our team. Their expertise, focus, and day to day discipline make growth possible without sacrificing quality.

We also thank our clients and partners for their continued trust. Long term collaboration, not quick wins, is what supports steady progress in a demanding and highly regulated industry.

Insuvia remains committed to clear thinking, high standards, and dependable execution across pharmacovigilance, drug safety, and regulatory affairs. We are proud of what four years on this list represent, and we are clear about what comes next, keep building, keep improving, and keep earning our place.

Read more about the FT 1000 rankings on: FT1000: Europe’s Fastest-Growing Companies 2026 ranking